Geneve, Geneva, Switzerland | Fund Name | Location |
| AMT Qiyuan | - |
| Argus Capital | England, London, United Kingdom |
| B-Seed Partners | - |
| BOC International Holdings | China, Hong Kong, Hong Kong Island |
| Daicheng Touzi | China, Shanghai |
| EVE Energy | China, Guangdong, Huizhou |
| GMS Capital Partners | District of Columbia, United States, Washington |
| HBK Capital Management | Dallas, Texas, United States |
| Huazhu Hotels Group | China, Shanghai, Shanghai |
| Kelso & Company | New York, New York, United States |
| letters Capital | - |
| Neurosearch | Ballerup, Denmark, Hovedstaden |
| Shenzhen Comix Holdings | China, Futian, Guangdong |
| Snapdragon Capital Partners | - |
| Tempus Partners | Australia, New South Wales, Sydney |
| The W.K. Kellogg Foundation | - |
| Tianjin Saixiang Technology | China, Nankai, Tianjin |
| Traction Camp | - |
| Wacai.com | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Shoreline Biosciences | $43M | 07 Feb 2021 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Shoreline Biosciences | $43M | 07 Feb 2021 | San Diego, California, United States |
